Christian Koch

9PUBLICATIONS
48CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

|Mar 30, 2026
Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia.

Mara Hofstetter, Laura Volta, Christian Koch

|Mar 17, 2026
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells.

Laura G Volta, Celeste Gobbi, Christian Koch

|Jan 06, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.

Roman R Schimmer, Nancy Klemm, Jonas Fullin

|Dec 17, 2025
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

Jonas Fullin, Ebru Topçu, Karolina A Zielińska

|Mar 31, 2025
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect.

Nancy Klemm, Roman R Schimmer, Nils K Konrad

Pageof 2

Frequent Collaborators

7 joint publications

Markus G Manz

5 joint publications

Christian Pellegrino

5 joint publications

Laura Volta

4 joint publications

Roman Schimmer